Gracell Biotechnologies Inc.: current_liabilities
| Value | {"amount": 14308000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3b6b1063-1a05-4a0e-b3e2-7de247c46647
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-128979Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/current-liabilities/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3b6b1063-1a05-4a0e-b3e2-7de247c46647
History
- supersedes {"unit": "CNY", "value": 93361000, "concept": "us-gaap:LiabilitiesCurrent"} (evidence 0001193125-21-128979)